Cysteine Metabolism - an overview
US$ 25.80
aod9604 fda approved AOD 9604 (5mg) - Nutritomic
Description
Notable recent developments include the first preclinical study demonstrating NNMT inhibition improves cardiac function and reduces fibrosis in a heart failure model (Li et al., 2025), a comprehensive review of NNMT as a therapeutic target for neurodegenerative disorders (Liu et al., 2025), and emerging evidence that NNMT inhibition counteracts tubular senescence and fibrosis in chronic kidney disease
More NAD+ boosts SIRT1 activity
For context, you can get that amount from about 4 ounces of ground beef
One of the concerns with GLP-1 therapy is muscle loss
